Carpenter Technology heads into its October 6 earnings report with a stock down 18% over the past month yet short sellers actively reducing exposure, a divergence that makes the setup worth examining closely.
The clearest shift in positioning is on the short side. Short interest has fallen nearly 9% over the week to 3.2% of the free float, and is down 30% over the past month. That unwind has been swift: shares short peaked near 2.25 million in late August and have steadily declined since, reaching roughly 1.58 million by September 29. The borrow market reflects the same story. Cost to borrow is a negligible 0.41%, well below the brief spike toward 0.67% seen in early September, and availability is extraordinarily loose at over 4,000% of short interest. There is no mechanical squeeze pressure here, and the shorts unwinding ahead of the print appear to be doing so without difficulty.
Options positioning tells a different story from the recent past. The put/call ratio has collapsed to 0.47, more than one standard deviation below its 20-day average of 0.68. Two months ago the PCR was running above 1.0, signalling heavy demand for downside protection. That demand has now reversed sharply. Call open interest dominates, suggesting that options traders are positioning for a rebound rather than hedging against further weakness. The 52-week PCR low is 0.11, so this is not an extreme reading, but the directional shift from defensive to offensive over the past six weeks is pronounced.
The Street remains constructive even after a busy round of target cuts following the July 30 results. Wells Fargo's David Strauss delivered the most recent move, cutting his target to $430 from $540 on September 30 while keeping an Equal-Weight rating. That note landed with the stock at $391.74, implying the stock is already trading near the low end of analyst expectations. The broader analyst picture is more optimistic: JP Morgan and Keybanc both hold Overweight ratings with targets of $700 and $608 respectively, and the mean price target across six buy-rated analysts is $626. That implies roughly 60% upside from current levels, a gap that reflects how sharply the stock has de-rated in recent months. The bull case rests on aerospace and defense demand, margin expansion in premium engine materials, and free cash flow growth. Bears point to supply chain risk and whether the company's pricing power can hold as volumes shift toward lower-margin structural products. Valuation has re-rated with the price decline: the trailing PE has compressed to 25.7 from around 31.7 a month ago, while price-to-book has dropped to 5.9. The 90-day EPS momentum factor scores in the 94th percentile, suggesting estimate revisions have been running positive even as the share price has fallen.
The institutional register is notable for one entry. Lone Pine Capital, a closely watched long/short hedge fund, trimmed its position by 855,000 shares as of June 30, reducing its stake to roughly 962,000 shares. That was a large move relative to the prior holding. JP Morgan Asset Management moved the other way, adding 691,000 shares to hold approximately 773,000. Among the very largest holders, BlackRock expanded its position to 12.5% of shares and FMR added modestly to its 8.1% stake. The CEO, Tony Thene, sold shares worth approximately $15.6 million across multiple tranches on August 25, none of which were flagged as being under a 10b5-1 pre-arranged plan. Director Steven Karol exercised options and immediately sold roughly $1.55 million of stock on September 4, also outside a formal plan. The net insider flow over the past 90 days is negative $54.6 million, driven almost entirely by those CEO sales at prices in the $480s, well above the current $391.74 close.
With earnings six days out and the stock having shed nearly 18% over the past month, the October 6 print becomes a test of whether the demand environment in aerospace and defense justifies the premium the stock commanded through most of 2026. What to watch is whether management commentary on the FY27 outlook closes the gap between the current price and an analyst consensus that still clusters well above $500.
See the live data behind this article on ORTEX.
Open CRS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
